Interaction of Blood Pressure Lowering and Alteplase Dose in Acute Ischemic Stroke: Results of the Enhanced Control of Hypertension and Thrombolysis Stroke Study
Date Issued
2020
Author(s)
VERONICA VIVIANA OLAVARRIA IANISZEWSKY
Type
Resource Types::text::journal::journal article
Subjects
acute ischemic stroke
;
thrombolysis
;
intracerebral hemorrhage
;
blood pressure lowering
;
hypertension
;
aged
;
aged, 80 and over
;
antihypertensive agents
;
blood pressure
;
brain ischemia
;
female
;
fibrinolytic agents
;
humans
;
hypertension
;
intracranial hemorrhages
;
male
;
middle aged
;
recovery of function
;
risk factors
;
stroke
;
thrombolytic therapy
;
time factors
;
tissue plasminogen activator
;
treatment outcome
;
alteplase
;
antihypertensive agent
;
fibrinolytic agent
;
tissue plasminogen activator
;
adult
;
aged
;
article
;
blood clot lysis
;
blood pressure monitoring
;
brain hemorrhage
;
brain ischemia
;
clinical outcome
;
comparative study
;
controlled study
;
ethnicity
;
female
;
follow up
;
functional neuroimaging
;
functional recovery
;
glasgow coma scale
;
hospital admission
;
hospital discharge
;
human
;
hypertension
;
image analysis
;
intensive care unit
;
low drug dose
;
major clinical study
;
male
;
mortality
;
national institutes of health stroke scale
;
outcome assessment
;
priority journal
;
randomized controlled trial
;
rankin scale
;
risk factor
;
sensitivity analysis
;
systolic blood pressure
;
adverse event
;
blood pressure
;
brain ischemia
;
cerebrovascular accident
;
clinical trial
;
convalescence
;
drug effect
;
fibrinolytic therapy
;
hypertension
;
middle aged
;
multicenter study
;
pathophysiology
;
time factor
;
treatment outcome
;
very elderly